Novartis AG must wait until Sept. 2 to sell the first biosimilar drug to be approved in the United States, a copycat version of Amgen Inc’s $1.2 billion-a-year Neupogen, a […]
CHAPEL HILL, N.C., July 17, 2015 /PRNewswire/ — The hepatitis C treatment Sovaldi had all the marketplace ingredients for blockbuster status when it was approved by the FDA in December 2013. […]
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals has launched four new products since June 2015. On July 13, the company obtained FDA approval for its tobramycin inhalation solution (a generic equivalent for Tobi® […]
LAKE FOREST, Ill., July 16, 2015 /PRNewswire/ — Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced it […]
Baxalta Incorporated, a pharmaceutical spinout of Illinois-based Baxter International (BAX), finally launched with hopes of fielding 20 new products by 2020, the company announced this morning. The new company, […]
North American expansion and committed funding to drive medium term growth. LONDON, June 26, 2015 /PRNewswire/ – Pro Bono Bio, the world’s leading nanotechnology company offering health and lifestyle products, […]
FORT WORTH, Texas, June 25, 2015 /PRNewswire/ — Alcon, the global eye care leader and a division of Novartis, announced today the US launch of CLEAR CARE® PLUS Cleaning & […]
R&D efforts on the part of major biopharmaceutical companies for novel drugs to treat depression and other CNS diseases have eroded over the past decade. In fact, a study published […]
Cipla Ltd, India’s fourth-largest drugmaker by revenue, expects sales from its respiratory drug portfolio to more than double by 2020 and remains on track to launch a keenly awaited inhaler […]
MIAMI–(BUSINESS WIRE)–Nicofi™ announced the launch of a revolutionary patented, fast-acting dissolvable nicotine tablet intended for use as an alternative to smoking. Nicofi is a small sublingual tablet made from pure […]